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Abstract
Introduction
Deficiencies in innate immune responses may contribute to the increased susceptibility to
infection in preterm infants. In vivo cytokine profiles in response to sepsis in very preterm
infants are not fully understood.
Aims
To characterise plasma pro- and anti-inflammatory cytokine concentrations and pre-defined
ratios in very preterm infants with late-onset sepsis (LOS).
Methods
In this observational study, peripheral blood samples were collected at the time of evaluation
for suspected LOS from 31 preterm infants (<30 weeks gestational age). Plasma cytokine
concentrations were determined by 12-plex immunoassay.
Results
IL-10, IFN-γ, IL-12p70, IP-10, IL-6 and CCL2 were elevated in the majority infants with LOS
(n = 12) compared to those without LOS (n = 19). There was no difference in TNF-α, IL-1β,
IL-17AF, IL-8 and IL-15 concentrations between groups. IL-10/TNF-α ratios were increased,
while CCL2/IL-10 and IL-12p70/IL-10 ratios were decreased in infants with LOS compared
to those without.
Conclusion
Very preterm infants have a marked innate inflammatory response at the time of LOS. The
increase in IL-10/TNF-α ratio may indicate early immune hypo-responsiveness. Longitudinal
studies with a larger number of participants are required to understand immune responses
and clinical outcomes following LOS in preterm infants.
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Introduction
Globally, approximately 15 million infants are born preterm (<37 weeks gestational age, GA)
each year, of which ~15% are born less than 32 weeks GA. [1] Preterm infants are susceptible
to invasive bacterial infections and the risk is associated with lower GA and birthweight. [2]
Despite advances in neonatal care, late-onset sepsis (LOS; occurring >72 hours after birth) is a
frequent complication in preterm infants, affecting up to 40% of infants born <28 weeks GA.
[2] Infection-related inflammation is associated with increased mortality and morbidity, par-
ticularly long-term adverse neurodevelopmental outcomes. [3]
The mechanisms underpinning the distinct neonatal immune responses to bacterial infec-
tions are incompletely understood. Pro- and anti-inflammatory cytokines are critical key initi-
ators and regulators of inflammation and host response to bacterial infection. [4] In adults,
both pro- and anti-inflammatory cytokines are simultaneously produced during the early
stages of sepsis and correlate with disease progression and mortality. [5] Elevated ratios of
anti- and pro-inflammatory cytokines (e.g. IL-10/TNF-α and IL-6/IL-10) are associated with
multiple organ failure and are proposed markers of sepsis-induced immunosuppression in
adult patients following sepsis. [6, 7] Recovery from sepsis may depend on the balance of pro-
and anti-inflammatory immune responses to achieve homeostasis. [8]
It is unclear whether the immediate response of preterm infants with LOS is hyper- or hypo-
inflammatory. [9] Cytokine concentrations at the time of neonatal sepsis are inconsistent, partly
as studies often include both LOS and early-onset sepsis (EOS; occurring<72 hours after birth),
[10–12] and a wide range of GA, [11, 13–18] making interpretation of cytokine responses chal-
lenging. We therefore aimed to characterise key cytokines [5] in plasma at the time of evaluation
for suspected LOS in a homogeneous cohort of very preterm infants (born<30 weeks GA)
enrolled in an observational cohort study of innate immune ontogeny. We also investigated
whether infants with LOS have increased pro- and anti-inflammatory cytokine responses and ele-
vated pre-defined cytokine ratios, as observed in adults, compared to neonates without LOS.
Materials and methods
Study participants
This study was approved by the Women and Newborn Health Services Human Research Eth-
ics Committee, Perth, Australia (1627/EW). Written, informed consent was obtained by the
Principal Investigator or delegate from the parent(s)/legal guardian prior to study participa-
tion. Infants born less than 30 weeks GA without birth defects or genetic abnormalities who
were admitted to the Neonatal Intensive Care Unit (NICU) at King Edward Memorial Hospi-
tal, Perth, Australia were eligible to participate in this prospective observational cohort study
of innate immune system ontogeny, with recruitment from July 2009 to October 2011. Sam-
ples taken at the time of evaluation for suspected LOS were collected opportunistically during
normal working hours from enrolled infants. Blood culture was performed on infants if they
had clinical signs suggestive of LOS, including increased ventilation or oxygen requirements,
lethargy, decreased perfusion, temperature instability, vomiting, feed intolerance, increased
apnoea and/or bradycardia. For ethical reasons only one blood sample was collected at the
time of sepsis evaluation, when the clinical decision was made to investigate sepsis and com-
mence antibiotic therapy. Infants who had episodes of EOS (n = 2) or necrotising enterocolitis
(NEC) prior to the episode of suspected LOS (n = 1) were excluded. Placental histology were
analyzed using an adaptation of a widely accepted semi-quantitative scoring system, as previ-
ously described. [19] Haematological parameters were recorded close to the time of blood cul-
ture sampling (mean ± SD, 124 ± 177 min).
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Definition of late-onset sepsis
‘Confirmed LOS’ was retrospectively defined as a positive blood culture with a single organism
and a C-reactive protein (CRP) of>15mg/L within 72hrs of blood culture sampling and anti-
biotic therapy for� 5 days, as per the local NICU guidelines during the study period. Episodes
without evidence for LOS, referred to as ‘no LOS’, were defined as a negative blood culture.
Four infants were considered to have contaminating blood cultures (based on the presence of
Gram-positive commensal bacteria, lack of an inflammatory response with two or more CRP
measurements <15mg/L and absence of clinical features of sepsis) were excluded from
analysis.
Blood sampling and processing for cytokine analyses
Approximately 0.5ml of peripheral blood was collected by venepuncture into Lithium-heparin
tubes (BD Biosciences, North Ryde, Australia) at the time of blood culture (68% of samples) or
close to the time of blood culture sampling (mean ± SD, 1.2 ± 2.6 hr). Sample processing and
analysis was performed at the Children’s Clinical Research Facility in Perth, Australia. Samples
were centrifuged at 6,000 x g for 2 minutes, and plasma extracted and stored at -80˚C until
cytokine measurement.
Multiplex immunoassay
Plasma cytokine concentrations were quantified using a custom 12-plex magnetic bead-based
immunoassay kit (ProcartaPlex Biosystems eBioscience, San Diego, California) following the
manufacturer’s instructions. The kit provided a mixture of magnetic beads conjugated with
primary antibodies against IL-1β, IL-6, IL-12p70, IL-15, IL-17AF, IL-8, IL-13, IL-10, TNF-α,
interferon (IFN)-γ, inducible protein (IP)-10 and chemokine (C-C motif) ligand-2 (CCL2).
Fluorescence for each cytokine bead region was acquired electronically in real time on the Bio-
Plex 200 System (Bio-Rad, Gladesville, Australia) and analysed using BioPlex Manager 5.0
Software. Cytokine concentrations, in pg/mL, were generated from a seven-point, five-param-
eter (four-parameter for IL-13) logistic standard curve. All samples analysed were run as a sin-
gle sample on one plate. Concentrations above the highest standard were repeated at a dilution
that fell within the standard curve. Concentrations below the lowest standard were assigned a
value of half the lowest standard for statistical analysis.
Statistical analysis
Continuous data were summarised with median and interquartile ranges (IQR, 25th-75th) and
categorical data with frequency distributions. All cytokine data were tested for normality using
the Shapiro-Wilk normality test and presented using nonparametric data summaries, medians
and IQR (25th-75th percentiles). Comparisons between the ‘confirmed LOS’ and ‘No LOS’
groups were by the Mann-Whitney test for continuous data and Chi-square tests for categori-
cal data. All statistical analysis was performed using Prism 8 software (Graphpad Software, San
Diego, California). P values <0.05 were considered significant.
Results
Study subject characteristics
There were no differences in the basic demographic and clinical details between the infants
with confirmed LOS (n = 12) and no LOS (n = 19), details are shown in Table 1. One infant
from the confirmed LOS group (sampled at 16 days postpartum) died aged 44 days of respira-
tory failure, and two infants in the no LOS group (both sampled at day 7 postpartum) died
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aged 19 and 56 days of NEC and respiratory failure, respectively. No other infants in the no
LOS group developed infections or NEC prior to discharge from the NICU.
The clinical parameters at the time of sepsis evaluation are shown in Table 2. For the 12 epi-
sodes of confirmed LOS, coagulase-negative staphylococci (CoNS) were the most common
infectious agents isolated (10 cases, 83%), consistent with local epidemiology. [20] All infants
recovered from the LOS episode.
Table 1. Basic demographic and clinical parameters of study cohorta.
Confirmed LOS (n = 12) No LOS (n = 19) P value
Gestational age (weeks) 26.7 (24.5–28.4) 25.6 (24.6–26.6) 0.383
Birthweight (grams) 835 (669–1101) 705 (555–895) 0.194
Male 4 (33.3) 12 (63.2) 0.149
Caesarean section 5 (41.7) 11 (57.9) 0.473
Membranes rupture >24h before delivery 4 (33.3) 9 (47.4) 0.484
Antenatal steroidsb 11/12 (91.7) 18/18 (100) 0.400
Histological chorioamnionitisb 5/11 (45.5) 9/16 (56.3) 0.704
Mechanical ventilation 12 (100) 19 (100) >0.999
Duration (hours) 241 (26.3–842) 394 (115–1091) 0.417
CPAP 12 (100) 18 (94.7) >0.999
Duration (hours) 1003 (771–1284) 1057 (563–1298) 0.723
IVH (grade III/IV) 0 (0) 2 (10.5) 0.510
ROP (stage III/IV) 0 (0) 1 (5.3) >0.999
Length of NICU stay (days) 83 (60–109) 109 (94–149) 0.150
aData are expressed as median (IQR) or n (%), as appropriate.
bFrom available reports. CPAP, continuous positive airway pressure; IVH, intraventricular haemorrhage; ROP, retinopathy of prematurity
https://doi.org/10.1371/journal.pone.0232933.t001
Table 2. Clinical parameters at the time of sepsis evaluation a.
Confirmed LOS (n = 12) No LOS (n = 19) P value
Age (days) 12 (9–14) 10 (7–15) 0.404
Gram-positive organisms
CoNS 10 (83.4) - -
Bacillus sphaericus 1 (8.3) - -
Enterococcus faecalis 1 (8.3) - -
CRP (mg/L)
Highest within 72hr blood culture 59 (26–91) 17 (5–30) 0.0008
At blood culture samplingb 20 (7–36) 12 (5–24) 0.106
White blood cell count (x109/L)c 14.5 (9.4–18.1) 24.8 (15.0–31.5) 0.095
Neutrophil count (x109/L)c 11.1 (5.0–15.4) 16.7 (9.6–20.0) 0.244
Platelet count (x109/L)c 137 (102–219) 215 (118–332) 0.253
Mechanical ventilation commenced 4 (33.3) 5 (26.3) 0.704
Inotrope use 0 (0) 0 (0) >0.999
aData are expressed as median (IQR) or n (%), as appropriate.
bAt or before (mean ± SD, 2.5 ± 2.5 hr) blood culture sampling.
cData available for n = 11 confirmed LOS and n = 18 no LOS. CoNS, coagulase-negative staphylococci; CRP, C-reactive protein.
https://doi.org/10.1371/journal.pone.0232933.t002
PLOS ONE Cytokine responses in neonatal sepsis
PLOS ONE | https://doi.org/10.1371/journal.pone.0232933 May 14, 2020 4 / 10
Circulating cytokine concentrations at the time of late-onset sepsis
evaluation
Overall, infants with confirmed LOS had markedly higher concentrations of IL-10, CCL2,
IFN-γ, IL-12p70, IL-13, IL-6 and IP-10 compared to no LOS, whereas concentrations of TNF-
α, IL-15, IL-1β, IL-17AF and IL-8 were similar in the two groups (Table 3). For IL-1β, IL-17AF
and IL-13, fewer than 25%, 15% and 10%, respectively, of concentrations were above the lowest
limit of detection, and results should be interpreted accordingly.
Analysis of anti- and pro-inflammatory ratios in infants with suspected
late-onset sepsis
We next evaluated whether the ratios of anti- and pro-inflammatory cytokine concentrations,
namely IL-10/TNF-α, IL-6/IL-10 and IP-10/IL-10, differed between groups, as previously
reported in adults [6] and infants. [12–14] Infants with confirmed LOS had a markedly ele-
vated IL-10/TNF-α and IP-10/IL-10 ratio compared to infants with no LOS (median (IQR) 10
(5–38) vs 0.9 (0.3–3), and 72 (38–144) vs 188 (82–533), respectively; Fig 1A and 1B), yet IL-6/
IL-10 was similar across groups (Fig 1C).
As concentrations of the pro-inflammatory cytokine IFN-γ, IL-12p70 and chemokine
CCL2 were associated with confirmed LOS, we evaluated the ratios of CCL2 to IL-10, IFN-γ to
IL-10 and IL-12p70 to IL-10 to determine if an anti- or pro-inflammatory response predomi-
nated. A low ratio of CCL2/IL-10 and IL-12p70/IL-10 were strongly associated with confirmed
LOS compared to the no LOS group (median (IQR) 38 (13–78) vs 286 (52–563) and 0.2 (0.03–
0.9) vs 1.9 (0.5–3.0), respectively. Fig 1D and 1E), but there was no difference in the IFN-γ/IL-
10 ratio between the patient groups (Fig 1F).
Discussion
In this study, we report that very preterm infants with microbially confirmed LOS had elevated
concentrations of both pro-inflammatory cytokines, IFN-γ, IP-10, IL-12p70, IL-6, CCL2 and
Table 3. Circulating cytokine concentrations at the time of late-onset sepsis evaluationa.
Multiplex pg/mL range Confirmed LOS (n = 12 episodes) No LOS (n = 19 episodes) P value
Minimum Maximum Median IQR Range Median IQR Range
IL-6 9.2 37,800 231 62.8–922 4.6–4309 4.6 4.6–149 4.6–2881 0.017
IFN-γ 12.4 50,700 347 65.7–712 6.2–1512 6.2 6.2–6.2 6.2–949 0.001
IL-12p70 6.9 28,100 32.8 3.4–72.7 3.4–85.7 3.4 3.4–24.4 3.4–39.3 0.049
TNF-α 7.2 29,500 9.1 6.1–32.2 3.6–49 6.1 3.6–14.0 3.6–23.2 0.168
IL-15 3.1 12,500 43.8 1.5–383 1.5–576 218 1.5–276 1.5–670 0.676
IL-1βb 2.0 8,250 1.0 1.0–9.7 1.0–164 1.0 1.0–3.8 1.0–33.1 0.861
IL-17AFb 6.1 25,000 3.1 3.1–332 3.1–960 3.1 3.1–3.1 3.1–347 0.172
IL-8 2.2 8,900 234 137–1103 51.1–5138 174 84.2–707 33.7–6628 0.164
IP-10 2.2 8,800 13079 8348–16026 2661–18013 1066 602–1498 57.6–16033 <0.0001
CCL2 4.8 19,500 3407 2428–7627 1780–15105 1350 473–2588 184–7701 0.002
IL-10 2.3 9,250 194 46.8–255 22.9–487 6.5 1.1–22.9 1.1–529 <0.0001
IL-13b 3.3 13,400 1.6 1.6–3.8 1.6–16.5 1.6 1.6–1.6 1.6–1.6 0.049
aData are expressed as median, IQR (25th-75th) and range in pg/mL.
bFewer than 25% of data points in both groups are above the lowest detectable standard. LOS, late-onset sepsis; IL, interleukin; IFN, interferon; IP, inducible protein,
CCL2, chemokine (C-C motif) ligand-2; TNF, tumour necrosis factor; ns, not statistically significant. Level of significance measured by Mann-Whitney test.
https://doi.org/10.1371/journal.pone.0232933.t003
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the anti-inflammatory cytokine IL-10, compared to those without LOS. TNF-α levels were rel-
atively reduced in infants with LOS. Furthermore, we observed an elevated IL-10/TNF-α ratio
and decreased CCL2/IL-10 and IL-12p70 ratios in infants with confirmed LOS, compared to
the no LOS group.
Elevated circulating cytokine concentrations are associated with late-onset
sepsis
Elevated plasma concentrations of IL-10, IFN-γ, IP-10, IL-12p70, IL-6 and CCL2, were
strongly associated with confirmed LOS compared to no LOS; consistent with other preterm
infant sepsis studies. [10, 13, 14, 16, 18]. Concentrations of TNF-α, IL-1β, IL-17AF and IL-8
were similar between the two groups. Published concentrations of TNF-α, IL-1β, IL-17AF and
IL-8 in infants with sepsis are inconsistent, with some studies reporting results similar to ours,
[10–12, 15, 17] and others reporting higher cytokine concentrations in septic infants. [14–17]
The reasons underlying these discrepant results are unclear. Several factors may affect cytokine
concentrations, including GA, [10] EOS vs LOS (which generally have different aetiologies),
[12] sepsis definition (culture proven vs clinical sepsis) [15] and inclusion of Gram-negative,
fungal and NEC-related infections (which may elicit different cytokine responses). [13] To our
knowledge, this is the first study to measure IL-15 in neonates with and without sepsis. IL-15
has anti-apoptotic properties that may prevent sepsis-induced apoptosis of immune cells in
septic patients, [21]. Similar to adult sepsis studies, [22] we did not observe a difference in IL-
15 between preterm infants with and without sepsis.
Cytokine ratios as potential indicators of neonatal late-onset sepsis
The elevated ratio of IL-10/TNF-α in infants with confirmed LOS may indicate early immune
hypo-responsiveness. Elevated ratio of IL-10/TNF-α has been observed in adult sepsis data
and suggested to indicate sepsis-induced immunosuppression, [6]; it may therefore indicate
relative immunosuppression in preterm infants with sepsis. The balance between these cyto-
kines may be important in sepsis pathogenesis and susceptibility to infections in preterm
infants, as described in other children and adults with sepsis. [6, 23] Other studies report
markedly lower levels of LPS-, R848-, and LPS/ATP-induced TNF-α/IL-10 ratios in neonatal
cord blood compared to adult peripheral blood, and an increased LPS-stimulated IL-10/TNF-
α ratio in cord blood from infants born very preterm compared to moderate and late preterm.
[24, 25] Further, peripheral blood from infants with LOS had a markedly higher IL-10/TNF-α
ratio following stimulation with live Staphylococcus epidermidis compared to uninfected
infants, indicating infected infants have an impaired immune response to bacteria. [26] This
suggests that a marked anti-inflammatory response may be characteristic of infants and partic-
ularly those who are very preterm. Our results of elevated IL-10/TNF-α and decreased IP-10/
IL-10 ratios are similar to other studies looking at septic neonates with disseminated intravas-
cular coagulation (DIC). [13, 14]
We did not observe a difference in the IL-6/IL-10 ratio between groups. Previous studies
report an elevated IL-6/IL-10 ratio in septic infants, [12] and specifically in those with
Fig 1. Cytokine ratio at the time of late-onset sepsis evaluation. Comparison of a) IL-10/TNF-α, b) IP-10/IL-10, c) IL-6/IL-10, d)
CCL2/IL-10, e) IL-12p70/IL-10 and f) IFN-γ/IL-10 from infants with confirmed LOS (n = 12 episodes, closed circles) and no LOS
(n = 19 episodes, closed triangles). Cytokines were measured by bead-based multiplex assay. All data shown on a log scale with
median with 95% confidence intervals. Symbols depict level of significance between confirmed LOS and no LOS groups (�P = 0.048;
��P = 0.003; ���P = 0.0002) by Mann-Whitney test. LOS, late-onset sepsis; IL, interleukin; IFN, interferon; IP, inducible protein;
CCL2, chemokine (C-C motif) ligand-2.
https://doi.org/10.1371/journal.pone.0232933.g001
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disseminated intravascular coagulation, which is often associated with fungal and Gram-nega-
tive bacterial infections that are known to elicit different cytokine responses. [13, 14] The
infants with LOS in our study had Gram-positive bacterial LOS and did not have DIC, which
may explain why an elevated ratio was not observed in our cohort. Further studies with well-
defined sepsis definitions are needed to resolve these discrepant findings.
The elevated CCL2 and IL-12p70 observed in LOS infants is consistent with data on neona-
tal [11, 14, 16] and adult sepsis. [5] To our knowledge, this is the first study to report lower
ratios of CCL2/IL-10 and IL-12p70/IL-10 in infants with LOS compared to infants without
LOS. The role of CCL2, a member of the chemokine CC subfamily with potent monocyte che-
motactic activity, in sepsis is unclear. In a murine model of caecal ligature and puncture-
induced infection, higher levels of CCL2 modulates peritoneal bacterial clearance, suggesting
CCL2 is important in antimicrobial defence. [27] In contrast, adult studies report that sepsis
mortality is associated with increased CCL2, [5] potentially due to chemotaxis of innate leuko-
cytes and marked production of pro-inflammatory cytokines that contribute to organ failure,
septic shock and death. [28] Elevated levels of IL-12p70, an IFN-γ inducing pro-inflammatory
cytokine, have been reported in other preterm infant sepsis studies. [18] Further studies inves-
tigating the role of CCL2 and IL-12p70 in LOS in preterm infants are warranted.
Study strengths and limitations
This is the first study to show a skewed anti-inflammatory response in very preterm infants
with only Gram-positive LOS. Our study focused on a well-defined population of very preterm
infants with LOS, which may reduce some of the inter-individual variability seen in other neo-
natal studies. We acknowledge some limitations, including modest sample size, which pre-
cluded investigation of rarer Gram-negative and fungal associated LOS and infrequent
outcomes, such as septic shock and death. We were unable to collect serial samples over the
course of the episode and therefore lack important kinetic data. Lastly, it was not considered
ethical to take blood samples from very preterm infants without clinical indication, so the no
LOS group had clinical signs that led to investigations for sepsis at the time of sample collec-
tion. This group, therefore, may not be representative of responses in otherwise healthy very
preterm infants.
Conclusions
Very preterm infants with LOS have elevated concentrations of both pro- and anti-inflamma-
tory cytokines with a prominent shift to an anti-inflammatory immune response. These results
suggest that neonatal LOS maybe associated with a hypo-responsiveness, similar to sepsis-
induced immunosuppression observed in adults. Consistently reported patterns of cytokines
production associated with sepsis may lead new diagnostic methods, prognostic tools and
highlight possible therapeutic targets. Future studies should further explore the kinetic profile
of circulating cytokines in preterm infants with sepsis by serial sampling over the course of the
septic episode and ideally would be powered to evaluate associations between cytokine profile
and disease severity and outcomes.
Acknowledgments
Authors would like to acknowledge the assistance of Gail Abernethy, Annie Chang, Chooi
Heen Kok and the nursing staff at King Edward Memorial Hospital NICU for recruitment and
sample collection. We would like to thank Professor Dorota Doherty and Ms Liz Nathan (both
of University of Western Australia) for statistical advice. Lastly, we would like to thank all the
study participants and their families.
PLOS ONE Cytokine responses in neonatal sepsis
PLOS ONE | https://doi.org/10.1371/journal.pone.0232933 May 14, 2020 8 / 10
Author Contributions
Conceptualization: Julie Hibbert, Tobias Strunk, Karen Simmer, Peter Richmond, David
Burgner.
Formal analysis: Julie Hibbert.
Funding acquisition: Tobias Strunk, Karen Simmer, Peter Richmond, David Burgner,
Andrew Currie.
Investigation: David Burgner, Andrew Currie.
Methodology: Julie Hibbert, Tobias Strunk, Andrew Currie.
Project administration: Julie Hibbert.
Supervision: Tobias Strunk, Karen Simmer, David Burgner, Andrew Currie.
Writing – original draft: Julie Hibbert.
Writing – review & editing: Tobias Strunk, Karen Simmer, Peter Richmond, David Burgner,
Andrew Currie.
References
1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and
worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected
countries: a systematic analysis and implications. Lancet. 2012; 379:2162–72. https://doi.org/10.1016/
S0140-6736(12)60820-4 PMID: 22682464
2. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very
low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;
110:285–91. https://doi.org/10.1542/peds.110.2.285 PMID: 12165580
3. Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O. Infection-induced inflammation and cerebral
injury in preterm infants. Lancet Infect Dis. 2014; 14:751–62. https://doi.org/10.1016/S1473-3099(14)
70710-8 PMID: 24877996
4. Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, et al. Role of cytokines as a double-
edged sword in sepsis. In Vivo. 2013; 27:669–84. PMID: 24292568
5. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers
of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11:R49. https://doi.org/10.1186/
cc5783 PMID: 17448250
6. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in
patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;
181:176–80. https://doi.org/10.1086/315214 PMID: 10608764
7. Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S. Anti-inflammatory cytokine response and the devel-
opment of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand. 2003; 47:319–25. https://
doi.org/10.1034/j.1399-6576.2003.00004.x PMID: 12648199
8. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions
to immunotherapy. Nat Rev Immunol. 2013; 13:862–74. https://doi.org/10.1038/nri3552 PMID:
24232462
9. Hibbert JE, Currie A, Strunk T. Sepsis-Induced Immunosuppression in Neonates. Front Pediatr. 2018;
6:357. https://doi.org/10.3389/fped.2018.00357 PMID: 30555806
10. Segura-Cervantes E, Mancilla-Ramirez J, Gonzalez-Canudas J, Alba E, Santillan-Ballesteros R, Mora-
les-Barquet D, et al. Inflammatory Response in Preterm and Very Preterm Newborns with Sepsis. Medi-
ators Inflamm. 2016; 2016:6740827. https://doi.org/10.1155/2016/6740827 PMID: 27293317
11. Leal YA, Alvarez-Nemegyei J, Lavadores-May AI, Giron-Carrillo JL, Cedillo-Rivera R, Velazquez JR.
Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med.
2018:1–7.
12. Ye Q, Du LZ, Shao WX, Shang SQ. Utility of cytokines to predict neonatal sepsis. Pediatr Res. 2017;
81:616–21. https://doi.org/10.1038/pr.2016.267 PMID: 27997530
PLOS ONE Cytokine responses in neonatal sepsis
PLOS ONE | https://doi.org/10.1371/journal.pone.0232933 May 14, 2020 9 / 10
13. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G, et al. Proinflammatory and anti-inflammatory cytokine
responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed. 2003; 88:
F209–13. https://doi.org/10.1136/fn.88.3.F209 PMID: 12719394
14. Ng PC, Li K, Leung TF, Wong RP, Li G, Chui KM, et al. Early prediction of sepsis-induced disseminated
intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem.
2006; 52:1181–9. https://doi.org/10.1373/clinchem.2005.062075 PMID: 16613997
15. Silveira-Lessa AL, Quinello C, Lima L, Redondo ACC, Ceccon M, Carneiro-Sampaio M, et al. TLR
expression, phagocytosis and oxidative burst in healthy and septic newborns in response to Gram-neg-
ative and Gram-positive rods. Hum Immunol. 2016; 77:972–80. https://doi.org/10.1016/j.humimm.
2016.07.230 PMID: 27450230
16. Sugitharini V, Prema A, Berla Thangam E. Inflammatory mediators of systemic inflammation in neonatal
sepsis. Inflamm Res. 2013; 62:1025–34. https://doi.org/10.1007/s00011-013-0661-9 PMID: 24013483
17. Tosson AMS, Glaser K, Weinhage T, Foell D, Aboualam MS, Edris AA, et al. Evaluation of the S100
protein A12 as a biomarker of neonatal sepsis. J Matern Fetal Neonatal Med. 2018:1–191.
18. Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, et al. Utility of interleukin-12
and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of
neonatal sepsis. Am J Perinatol. 2008; 25:629–36. https://doi.org/10.1055/s-0028-1090585 PMID:
18850512
19. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome:
nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003; 6:435–48. https://
doi.org/10.1007/s10024-003-7070-y PMID: 14708737
20. Isaacs D, Barfield C, Clothier T, Darlow B, Diplock R, Ehrlich J, et al. Late-onset infections of infants in
neonatal units. J Paediatr Child Health. 1996; 32:158–61. https://doi.org/10.1111/j.1440-1754.1996.
tb00914.x PMID: 9156527
21. Inoue S, Unsinger J, Davis CG, Muenzer JT, Ferguson TA, Chang K, et al. IL-15 prevents apoptosis,
reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol. 2010;
184:1401–9. https://doi.org/10.4049/jimmunol.0902307 PMID: 20026737
22. Jekarl DW, Kim JY, Ha JH, Lee S, Yoo J, Kim M, et al. Diagnosis and Prognosis of Sepsis Based on
Use of Cytokines, Chemokines, and Growth Factors. Dis Markers. 2019; 2019:1089107. https://doi.org/
10.1155/2019/1089107 PMID: 31583025
23. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, et al. Genetic
influence on cytokine production and fatal meningococcal disease. Lancet. 1997; 349:170–3. https://
doi.org/10.1016/s0140-6736(96)06413-6 PMID: 9111542
24. Speer EM, Dowling DJ, Ozog LS, Xu J, Yang J, Kennady G, et al. Pentoxifylline inhibits TLR- and
inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy
and potency in newborns. Pediatr Res. 2017; 81:806–16. https://doi.org/10.1038/pr.2017.6 PMID:
28072760
25. Dembinski J, Behrendt D, Martini R, Heep A, Bartmann P. Modulation of pro- and anti-inflammatory
cytokine production in very preterm infants. Cytokine. 2003; 21:200–6. https://doi.org/10.1016/s1043-
4666(02)00498-2 PMID: 12788309
26. Strunk T, Hibbert J, Doherty D, Nathan E, Simmer K, Richmond P, et al. Impaired cytokine responses to
live Staphylococcus epidermidis in preterm infants precede Gram-positive late-onset sepsis. Clin Infect
Dis. 2020.
27. Gomes RN, Teixeira-Cunha MG, Figueiredo RT, Almeida PE, Alves SC, Bozza PT, et al. Bacterial
clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide. Shock. 2013; 39:63–9. https://
doi.org/10.1097/SHK.0b013e31827802b5 PMID: 23247123
28. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodula-
tory mediators in sepsis. J Leukoc Biol. 2013; 93:329–42. https://doi.org/10.1189/jlb.0912437 PMID:
23136259
PLOS ONE Cytokine responses in neonatal sepsis
PLOS ONE | https://doi.org/10.1371/journal.pone.0232933 May 14, 2020 10 / 10
